PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference Stockholm, December 13, 2018. PledPharma AB (publ) announces that the company's Aladote® Phase Ib/IIa study results has been accepted for a poster presentation during the “58th Annual Meeting of the...